The spacer-modified trisaccharides that mimic (1----6)-linked beta-D-galactotetraose (Gal4), namely, O-beta-D-galactopyranosyl-(1----6)-S-beta-D-galactopyranosyl-(1----11)-8 -azi- 6,7,8,9,10-pentadeoxy-11-thio-D-galacto-undecose (12) and O-beta-D-galactopyranosyl-(1----6)-O-beta-D-galactopyranosyl- (1----13)-8-azi-6,7,8,9,10,11,12-heptadeoxy-D-galacto-tri decose (20) were synthesised by coupling disaccharide derivatives with 8-azi-6,7,8,9,10-pentadeoxy-1,2:3,4-di-O-isopropylidene-11-O -tosyl-alpha-D-galacto-undecopyranose (10) and 8-azi-6,7,8,9,10,11,12-heptadeoxy-1,2:3,4-di-O-isopropyli den e-alpha-D-galacto- tridecopyranose (17), respectively. Compounds 12 and 20 had affinities for the combining sites of the antibodies IgA X24 and IgA J 539 similar to those of O-beta-D-galactopyranosyl-(1----6)-O-beta-D- galactopyranosyl-(1----11)-8-azi-6,7,8,9,10-pentadeoxy-D-gal acto-undecose (7) and the native ligand Gal4. Tritium-labelled 7 chemically modified the heavy and light chains of IgA J 539, whereas 8-azi-6,7,8,9,10-pentadeoxy-D-(11-3H)galacto-undecose (5a) reacted only with the heavy chain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0008-6215(92)80040-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical significance of glomerular IgM deposit in IgA nephropathy: a 5-year follow-up study.
Ren Fail
December 2024
Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, PR China.
Article Synopsis
- The study investigates the role of glomerular IgM deposit intensity in patients with IgA Nephropathy (IgAN) from January 2018 to May 2023, categorizing patients into IgM+ and IgM- cohorts based on the presence of these deposits.
- Among 982 IgAN patients, 539 tested positive for IgM deposits, with further division into IgM-H and IgM-L based on deposit intensity.
- Findings indicate that while IgM deposits didn't negatively affect overall outcomes, higher intensity (IgM-H) correlated with increased kidney damage and poorer clinical measures, making it a potential independent risk factor in IgAN patients.
Autoantibodies Targeting Nephrin in Podocytopathies.
N Engl J Med
August 2024
From the III. Department of Medicine (F.E.H., S.D., M.L., G.Z., L.S., A.S., O.K., F.G., R.L., L.M.M., E.H., M.M.R., N.M.T., T.B.H.) and the Departments of Medical Biometry and Epidemiology (H.O.P.), Pathology (T.Z., T.W.), Pediatric Nephrology (J.O.), and Obstetrics and Fetal Medicine (A.D.), Hamburg Center for Kidney Health (F.E.H., S.D., M.L., G.Z., L.S., A.S., O.K., F.G., R.L., L.M.M., J.O., E.H., M.M.R., N.M.T., T.B.H.), and the Hamburg Center for Translational Immunology (N.M.T., T.B.H.), University Medical Center Hamburg-Eppendorf, Hamburg, and the Center for Pediatrics and Adolescent Medicine, University Hospital Heidelberg, Heidelberg (F.S.) - all in Germany; the Department of Biomedicine, Aarhus University, Aarhus, Denmark (F.D., A.M.B., M.M.R.); the Department of Precision and Regenerative Medicine and Ionian Area, Nephrology, Dialysis, and Transplantation Unit, University of Bari Aldo Moro, Bari (A.M., P.P., L.G.), and the Division of Nephrology, Bambino Gesù Children's Hospital, IRCCS, Rome (M.C., F.E., M.V.) - both in Italy; INSERM, Unité Mixte de Recherche S 1155, Sorbonne Université (H.D., P.R.), and the Pediatric Nephrology Department, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris (C.D., J.H.), Paris, and the Division of Nephrology, Centre Hospitalier du Mans, Le Mans (P.R.) - all in France; the Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, and the Department of Pediatrics, Ohio State University College of Medicine - both in Columbus (W.E.S.); the Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School - both in Boston (A.W.); and the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore (N.A.).
Background: Minimal change disease and primary focal segmental glomerulosclerosis in adults, along with idiopathic nephrotic syndrome in children, are immune-mediated podocytopathies that lead to nephrotic syndrome. Autoantibodies targeting nephrin have been found in patients with minimal change disease, but their clinical and pathophysiological roles are unclear.
Methods: We conducted a multicenter study to analyze antinephrin autoantibodies in adults with glomerular diseases, including minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, IgA nephropathy, antineutrophil cytoplasmic antibody-associated glomerulonephritis, and lupus nephritis, as well as in children with idiopathic nephrotic syndrome and in controls.
Single cell sequencing data identify distinct B cell and fibroblast populations in stricturing Crohn's disease.
J Cell Mol Med
May 2024
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK.
Single cell RNA sequencing of human full thickness Crohn's disease (CD) small bowel resection specimens was used to identify potential therapeutic targets for stricturing (S) CD. Using an unbiased approach, 16 cell lineages were assigned within 14,539 sequenced cells from patient-matched SCD and non-stricturing (NSCD) preparations. SCD and NSCD contained identical cell types.
View Article and Find Full Text PDFA multi-center randomized controlled trial to investigate potential effects of exercise therapy on renal function stratified by renal disorders and renal pathology: beneficial or harmful effect in immunoglobulin a nephropathy.
Clin Exp Nephrol
June 2024
Department of Nephrology, International University of Health and Welfare, Narita Hospital, 852, Hatakeda, Narita, Chiba, 286-8520, Japan.
Article Synopsis
- A study was conducted to evaluate the impact of exercise therapy (ET) on renal function in chronic kidney disease (CKD) patients who had a recent renal biopsy.
- The trial involved 50 patients who participated in either a 24-week exercise program or usual care, measuring changes in kidney function and protein levels in urine.
- Results indicated that while ET did not improve kidney function overall, it showed potential benefits for patients with IgA nephropathy, helping to maintain their renal function and manage urinary protein levels better compared to those not receiving ET.
Urinary C4d and progression of kidney disease in IgA vasculitis.
Nephrol Dial Transplant
September 2024
Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University; Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang Province; Institute of Nephrology, Zhejiang University; Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, China.
Background: Immunoglobulin A (IgA) vasculitis nephritis (IgAVN) is the most common secondary IgA nephropathy (IgAN). Urinary C4d have been identified associated with the development and progression in primary IgAN; however, its role in kidney disease progression of IgAVN is still unclear.
Methods: This study enrolled 139 patients with IgAVN, 18 healthy subjects, 23 focal segmental glomerulosclerosis patients and 38 IgAN patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!